Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
暂无分享,去创建一个
Y. Menda | D. Bushnell | T. O'Dorisio | M. Madsen | D. Kahn | M. Connolly | H. Bouterfa | T. Carlisle | M. Karwal | James Ponto | S. O'dorisio | Sara Miller | S. Squires | W. Walkner